Clinical Trials Arena February 21, 2024
The funding will support clinical trials slated to commence in H1 2024 and develop the device’s wireless power source.
US-based BiVACOR has been awarded $13m from the Australian Government’s Medical Research Future Fund (MRFF) to advance its total artificial heart programme.
With a presence in Australia, BiVACOR was chosen as part of an A$50m ($33m) grant by the government through the Artificial Heart Frontiers Programme (AHFP).
Along with the medtech company, five universities and three clinical groups form the Australia-based consortium to develop and commercialise artificial hearts.
BiVACOR stated that the funding will help with the development of a wireless power source for the devices, along with supporting clinical trials.
US-based Syncardia Systems has developed the only total artificial heart...
Today's Sponsors
Today's Sponsor